Giuditta Snider
 |
A piloted body system-based questionnaire was distributed to patients registered with 79 medical online pharmacy female contraceptive pills practices in Grampian prescribed one of nine recently marketed 'black triangle' drugs. All symptoms reported were classified, taking into account information provided by patients on their online pharmacy concomitant drugs and diseases. A sample of medical records was examined to compare symptoms recorded with those reported by patients. The hair removal no prescription pharmacies median per patient was 6.0 (range 0--71), with almost half (406, 48.5%) reporting fewer than five symptoms. The results suggest that patients do not tramadol pharmacy report all symptoms they suspect to be ADRs to their GP and that GPs do not record all symptoms which may be reported to them. Of the 742 reporting symptoms in questionnaires, 402 (54.2%) claimed to have reported some or all of these to their doctor. Patients reporting alesse large numbers of symptoms were more likely to report some which were classed as unlikely to be an ADR or unattributable (chi2 80.587, d.f. A methodological study.AIMS. Only 162 (22.6%) of 716 patient-reported symptoms were documented in the hair removal primary care medical records of 103 patients prescribed Tramadol ( Generic Ultram ) or venlafaxine. A classification system was developed for the study to enable the assessment of symptoms reported for their tramadol drug potential relationship to patients' drug therapy. Respondents were clearly willing to report symptoms, the majority of which were classed as possibly/probably related to the drugs studied. The method could help to identify problems which patients perceive as being related to their drug therapy and contribute to increased ADR reporting.. Responses from patients prescribed antidepressant drugs were more likely to include symptoms potentially caused by these drugs (74.5% of all symptoms reported) than those from patients prescribed analgesics (67.4%) or antiepileptics (65.1%, chi2 23.858, d.f. Patient reporting of potential adverse drug reactions. To develop a systematic generic method of enabling patients to report symptoms which they believe to be due to a particular prescribed drug. Agreement between researcher and specialist on the classification of 75.3% of 716 symptoms was obtained (Kappa 0.563). Most symptoms (71.0%) were classified as being probably or possibly related to the drugs studied. These comprised four antidepressants, three antiepileptics and two analgesics. A 36.3% response rate was obtained (837/2307) with 742 respondents (88.6%) reporting at least one symptom. A specialist pharmacist independently re-classified a exemplary of the symptoms to validate the process. This requested respondents to identify any symptoms experienced over the previous year which they thought could be due to the 'black triangle' drug they had used.
|
